The U.S Amoxicillin Trihydrate prices entered June 2026 with a modest correction after recording notable gains in May. During the first half of June, Amoxicillin Trihydrate prices declined by 0.87%, primarily due to slower procurement activity among pharmaceutical importers following aggressive inventory replenishment in the previous month. While demand from healthcare and pharmaceutical manufacturing sectors remained stable, buyers increasingly relied on existing inventories to meet near-term production requirements, reducing immediate purchasing pressure. In May, Amoxicillin Trihydrate prices had risen by 2.1% month-on-month, supported by higher costs for Penicillin G Sodium, 6-APA, and pharmaceutical-grade glucose. These elevated feedstock expenses increased production costs and encouraged exporters from China and India to raise quotations. Stable logistics conditions also contributed to firm landed costs in the U.S. market. Looking ahead, the Amoxicillin Trihydrate market is expected to remain largely stable through the remainder of June. Improved export availability from China and India is anticipated to support supply conditions, while steady demand from pharmaceutical manufacturers and hospitals should provide a stable consumption base. Overall, Amoxicillin Trihydrate prices are likely to fluctuate within a narrow range as balanced supply-demand fundamentals offset recent inventory-driven weakness.
